Article
Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma
2022-06-16
Abstract excerpt
Temozolomide (TMZ) resistance is a major clinical challenge for glioblastoma (GBM). O 6 -methylguanine-DNA methyltransferase (MGMT) mediated DNA damage repair is a key mechanism for TMZ resistance. However, MGMT-null GBM patients remain resistant to TMZ, and the process for resistance evolution is largely unknown. Here, we developed an acquired TMZ resistant xenograft model using serial implantation of MGMT-null U...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d6d4182a-6b85-5101-bbbd-ff5bfc118a71
- DOI
- 10.21203/rs.3.rs-1700654/v1
